Osteoporosis currently affects up to one in three women and one in 12 men. In 1990, there were 1.6 million hip fractures per annum worldwide and this number is estimated to reach 6 million by 2050. This increase in the number of fractures is due to an increase in the number of elderly people in the population, improved survival, and an increase in the age-specific fracture rates of unknown etiology. The rising number of osteoporotic fractures and their associated morbidity will place a heavy burden on future health care resources. In the United States, the cost for the management of osteoporosis has been estimated at $17 billion. The majority of this cost is spent on the acute surgical and medical management following hip fracture, and the subsequent rehabilitation. Currently, only minimal costs are utilized for treatment and prevention of osteoporosis. Hopefully, however, an accurate assessment of the burden of osteoporosis on the individual and the health care system will enable the targeting of resources to tackle this growing problem. With an increasing number of effective pharmaceutical interventions, it is critical that these agents are targeted to those at greatest risk for future fracture. This will ultimately reduce the burden of osteoporosis in future years.
Unable to display preview. Download preview PDF.
References and Recommended Reading
- 1.World Health Organization: Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Geneva: WHO Technical Report Series.WHO 1994.Google Scholar
- 3.National Osteoporosis Foundation: http:/www.nof.org/ osteoporosis. This website is a useful source of information on osteoporosis.Google Scholar
- 5.National Osteoporosis Foundation: Osteoporosis: review of the evidence for prevention, diagnosis and treatment and cost-effectiveness analysis. Status report from the National Osteoporosis Foundation. Osteoporos Int 1998 8(Suppl 4):10.Google Scholar
- 7.Genant HK, Cooper C, Poor G, et al.: Interim report and recommendations of the World Health Organization task force for osteoporosis. Osteoporos Int 1999, 10:259–264. This paper highlights current thinking, from the World Health Organization, on the scale of the osteoporosis epidemic.PubMedCrossRefGoogle Scholar
- 9.Dennison E, Cooper C: Epidemiology of osteoporotic fractures. Horm Res 2000, 54:S58-S63. This paper provides a useful overview on the epidemiology of osteoporosis.Google Scholar
- 10.Hoffenberg R, James OFW, Brocklehurst JC, et al.: Fractured neck of femur: prevention and management. J R Coll Physicians Lond 1989, 23:81–82.Google Scholar
- 18.Ismail AA, O’Neill TW, Cooper C, et al.: Mortality associated with vertebral deformity in men and women: results from the European Prospective Ostoporosis Study (EPOS). Osteoporos Int 1998, 8:291–297. An important paper illustrating the impact of incident fractures on mortality from a European perspective.PubMedCrossRefGoogle Scholar
- 30.Nevitt MC, Thompson DE, Black DM, et al.: Effect of alendronate on limited-activity days and bed-disability days caused by back pain in postmenopausal women with existing vertebral fractures. Arch Intern Med 2000, 160:77–85. An important paper illustrating that treatment to reduce osteoporosis fracture risk is also associated with an impact on improving patients quality of life.PubMedCrossRefGoogle Scholar
- 31.Dolan P, Torgersen D: The cost of treating osteoporotic fractures in the United Kingdom female population. Osteoporos Int 1998, 8:611–617. A detailed analysis of the costs associated with osteoporosis and fracture. Although slightly dated, the overall models and assumptions are still valid.PubMedCrossRefGoogle Scholar